Teladoc Health Inc
TDOC
NYSE
Health Care
$7.13
USD
+0.45 (+6.74%)
At close: Aug 7, 2026, 4:00 PM EDT
Market Cap $1.30B
Volume 4.8M
Revenue
$2.49B
TTM
-2.1%
YoY
Gross Margin
69%
TTM
-1.8%
YoY
Net Income
$-177.40M
TTM
+14.4%
YoY
Operating Cash Flow
$261.18M
TTM
-13.9%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 631.9 | 626.4 | 642.3 | 613.8 | 606.9 |
YoY Growth | -1.6% | -2.2% | +0.3% | -2.5% | -4.0% |
Cost of Revenue | 190.5 | 187.2 | 197.0 | 197.5 | 190.8 |
Gross Profit | 441.4 | 439.3 | 445.2 | 416.3 | 416.1 |
Selling, General & Administrative | 325.6 | 318.8 | 305.7 | 304.9 | 296.8 |
Other Operating Expenses | 5.7 | 16.5 | 9.0 | 13.0 | 0.9 |
Total Operating Expenses | 493.1 | 491.2 | 481.2 | 478.1 | 451.5 |
Operating Income | -51.7 | -52.0 | -36.0 | -61.8 | -35.4 |
EBITDA | 47.0 | 52.9 | 67.9 | 43.6 | 56.4 |
Other Income / Expense | 5.7 | -0.8 | 0.4 | -0.2 | -3.9 |
Total Other Income / Expense | 11.3 | 1.7 | 2.4 | 0.9 | -2.5 |
Income Before Income Taxes | -40.4 | -50.2 | -33.6 | -60.8 | -37.9 |
Income Taxes | -7.8 | -0.7 | -8.5 | 3.0 | 1.0 |
Net Income | -32.7 | -49.5 | -25.1 | -63.8 | -38.9 |
Consolidated Net Income / Loss | -32.7 | -49.5 | -25.1 | -63.8 | -38.9 |
Net Income Attributable to Common Shareholders | -32.7 | -49.5 | -25.1 | -63.8 | -38.9 |
Basic EPS | -$0.19 | -$0.28 | -$0.14 | -$0.36 | -$0.21 |
Diluted EPS | -$0.19 | -$0.28 | -$0.14 | -$0.36 | -$0.21 |
Basic Shares Outstanding | 175.9M | 176.9M | 176.2M | 179.1M | 181.0M |
Diluted Shares Outstanding | 175.9M | 176.9M | 176.2M | 179.1M | 181.0M |